S. Salot

IL-21-Mediated Potentiation of Antitumor Cytolytic and Proinflammatory Responses of Human Vγ9Vδ2 T Cells for Adoptive Immunotherapy1

M. Bonneville, C. Harly, E. Scotet, 2009, The Journal of Immunology.

Large scale expansion of Vgamma9Vdelta2 T lymphocytes from human peripheral blood mononuclear cells after a positive selection using MACS "TCR gamma/delta+ T cell isolation kit".

B. Dréno, C. Bonnafous, H. Sicard, 2009, Journal of immunological methods.

Phase-I study of Innacell γδ™, an autologous cell-therapy product highly enriched in γ9δ2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma

M. Rimbert, I. Philip, E. Bompas, 2008, Cancer Immunology, Immunotherapy.

Large scale expansion of ?9d2 T lymphocytes: Innacell ?d cell therapy product

C. Laplace, B. Dréno, F. Romagné, 2007 .

Large scale expansion of gamma 9 delta 2 T lymphocytes: Innacell gamma delta cell therapy product.

C. Laplace, B. Dréno, F. Romagné, 2007, Journal of immunological methods.

DNAX accessory molecule‐1 (CD226) promotes human hepatocellular carcinoma cell lysis by Vγ9Vδ2 T cells

P. Loyer, F. Bouet, M. Le Gallo, 2009, European journal of immunology.

DNAX accessory molecule‐1 (CD226) promotes human hepatocellular carcinoma cell lysis by Vγ9Vδ2 T cells

P. Loyer, F. Bouet, M. Le Gallo, 2009, European journal of immunology.